Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
It is used to induce genomic instability in mice and modification of the kinetics of growth of Gram-negative bacteria
BN 50739 is an active compound
InChiKey: BMQGVNUXMIRLCK-YHVGWTKXSA-N
Trovafloxacin does not inhibit caspase 3/7 activation
InChi: InChI=1S/C23H28FN2O5P/c1-16-2-4-17(5-3-16)14-26-13-11-22(23(26)27)25-12-10-20(21(24)15-25)18-6-8-19(9-7-18)31-32(28
(-)-Cevimeline hydrochloride hemihydrate Catalog No.:M34745-C It is used to induce( ) Cevimeline hydrochloride hemihydrate (( ) SNI 2011), a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro metab. of SNI 2011 was also evaluated with rat and dog liver